• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Crispr Therapeutics Ag (NQ: CRSP )

    57.34 -0.58 (-1.00%)
    Streaming Delayed Price Updated: 10:49 AM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Crispr Therapeutics Ag

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    27 28 Next >
    3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
    Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine. 
    Via InvestorPlace
    3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
    Each of these three companies are entering a new era of growth. 
    Via The Motley Fool
    Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
    The price could be right for these three biopharma stocks. 
    Via The Motley Fool
    3 Stocks That Could Be the Next Big Thing in Gene Editing
    Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks. 
    Via InvestorPlace
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today
    Via Benzinga
    Is It Too Late to Buy CRISPR Therapeutics Stock?
    The biotech has been making a lot of noise since late last year. 
    Via The Motley Fool
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
    Via Benzinga
    Smart Money Is Betting Big In CRSP Options
    Via Benzinga
    The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024
    These undervalued Cathie Wood stocks capture her favorite trends and remain undervalued even as the wider tech sector surge. 
    Via InvestorPlace
    7 Biotech Stocks to Buy as Sector Rotation Ramps Up
    With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation. 
    Via InvestorPlace
    Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz
    On Tuesday, Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc (NASDAQ:COIN), despite Bitcoin (CRYPTO: BTC) reaching new 
    Via Benzinga
    It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
    Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
    Via Talk Markets
    The Top 3 Biotech Stocks to Buy in March 2024
    Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors. 
    Via InvestorPlace
    Here's Why CRISPR Therapeutics Stock Climbed 34% in February
    The biotech company keeps moving closer to bringing its promising first gene therapy to market. 
    Via The Motley Fool
    ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
    Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst
    This company's fortunes are likely to improve, and soon. 
    Via The Motley Fool
    A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
    The futures for these two beaten-down stocks could be brighter than their recent pasts. 
    Via The Motley Fool
    Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
    Both companies are working on treatments for genetic disorders. 
    Via Investor's Business Daily
    3 Biotech Stocks Bound to Blast Off By 2029
    Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years. 
    Via InvestorPlace
    3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
    Vertex shares have climbed almost 50% over the past year. 
    Via The Motley Fool
    Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
    Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs. 
    Via Benzinga
    3 Biotech Stocks to Buy and Hold for the Next 10 Years
    There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon. 
    Via The Motley Fool
    Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
    Buy this stock if you're daring, but avoid it for now if you aren't. 
    Via The Motley Fool
    Three S&P 500 Giants Lead This List Of Stocks Near Buy Points
    Watch these five stocks, but the market is slightly extended. 
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Stock Market Rallies To Record High On Nvidia: Weekly Review
    The stock market rally pulled back to start the week, but roared higher as booming Nvidia earnings and guidance fueled big AI-led gains. The S&P 500 and Dow Jones hit... Read More 
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Crispr Reports Its First Profit In 10 Quarters, And Shares Fly Out Of A Buy Zone
    The company recently gained approval in the U.S. and abroad for its first gene-editing drug. 
    Via Investor's Business Daily
    Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought
    These exciting players could deliver explosive growth over time. 
    Via The Motley Fool
    If You Invested $10,000 in CRISPR Therapeutics in 2019, This Is How Much You Would Have Today
    It would have been a great move. 
    Via The Motley Fool
    3 Stocks That Cathie Wood Is Loving Now: February 2024
    Looking for high-growth opportunities? Here are three Cathie Wood stocks for long-term investors to consider now. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    27 28 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.